JP2004534758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004534758A5 JP2004534758A5 JP2002589488A JP2002589488A JP2004534758A5 JP 2004534758 A5 JP2004534758 A5 JP 2004534758A5 JP 2002589488 A JP2002589488 A JP 2002589488A JP 2002589488 A JP2002589488 A JP 2002589488A JP 2004534758 A5 JP2004534758 A5 JP 2004534758A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- bistrifluoromethylbenzoyl
- diaza
- oxa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- -1 3,5-Bistrifluoromethylbenzoyl Chemical group 0.000 claims 2
- 102000002002 Neurokinin-1 Receptors Human genes 0.000 claims 2
- 108010040718 Neurokinin-1 Receptors Proteins 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 239000002464 receptor antagonist Substances 0.000 claims 2
- 229940044551 receptor antagonist Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 claims 2
- RAQBZJISSNCXQK-UHFFFAOYSA-N 2-[9-[3,5-bis(trifluoromethyl)benzoyl]-2-oxo-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-3-yl]-n,n-dimethylacetamide Chemical compound C1CN(C(=O)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)CCC21OC(=O)N(CC(=O)N(C)C)CC2C1=CC=CC=C1 RAQBZJISSNCXQK-UHFFFAOYSA-N 0.000 claims 1
- ZECJUCGRCJUNIL-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-3-(1-methylpiperidin-4-yl)-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound C1CN(C)CCC1N1C(=O)OC2(CCN(CC2)C(=O)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)C(C=2C=CC=CC=2)C1 ZECJUCGRCJUNIL-UHFFFAOYSA-N 0.000 claims 1
- UZUMYZSWGLGNIQ-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-3-(2-hydroxyethyl)-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound C1CN(C(=O)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)CCC21OC(=O)N(CCO)CC2C1=CC=CC=C1 UZUMYZSWGLGNIQ-UHFFFAOYSA-N 0.000 claims 1
- CVDHMAWLXZLZCR-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-3-(2-morpholin-4-ylethyl)-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CCC3(CC2)C(CN(CCN2CCOCC2)C(=O)O3)C=2C=CC=CC=2)=C1 CVDHMAWLXZLZCR-UHFFFAOYSA-N 0.000 claims 1
- MIGNBVWFGCBAJP-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-3-(3-hydroxypropyl)-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound C1CN(C(=O)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)CCC21OC(=O)N(CCCO)CC2C1=CC=CC=C1 MIGNBVWFGCBAJP-UHFFFAOYSA-N 0.000 claims 1
- USKRLFGVPFHMNS-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-3-(3-morpholin-4-ylpropyl)-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CCC3(CC2)C(CN(CCCN2CCOCC2)C(=O)O3)C=2C=CC=CC=2)=C1 USKRLFGVPFHMNS-UHFFFAOYSA-N 0.000 claims 1
- LSBVDIUKHIHORU-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-3-(4,6-dimethoxy-1,3,5-triazin-2-yl)-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound COC1=NC(OC)=NC(N2C(OC3(CCN(CC3)C(=O)C=3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)C(C=3C=CC=CC=3)C2)=O)=N1 LSBVDIUKHIHORU-UHFFFAOYSA-N 0.000 claims 1
- YUONGZINJMHEPL-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-3-[3-(3-hydroxypyrrolidin-1-yl)propyl]-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound C1C(O)CCN1CCCN1C(=O)OC2(CCN(CC2)C(=O)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)C(C=2C=CC=CC=2)C1 YUONGZINJMHEPL-UHFFFAOYSA-N 0.000 claims 1
- XJXLCXAGRLBBSN-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-5-(2,3-difluorophenyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC1=CC=CC(C2C3(CCN(CC3)C(=O)C=3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)OC(=O)NC2)=C1F XJXLCXAGRLBBSN-UHFFFAOYSA-N 0.000 claims 1
- JPGGKPOPGYJXRS-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-5-(2,5-difluorophenyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC1=CC=C(F)C(C2C3(CCN(CC3)C(=O)C=3C=C(C=C(C=3)C(F)(F)F)C(F)(F)F)OC(=O)NC2)=C1 JPGGKPOPGYJXRS-UHFFFAOYSA-N 0.000 claims 1
- KOOSRSYKRYWAAS-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-5-(3,4-dichlorophenyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CCC3(CC2)C(CNC(=O)O3)C=2C=C(Cl)C(Cl)=CC=2)=C1 KOOSRSYKRYWAAS-UHFFFAOYSA-N 0.000 claims 1
- HGXVVFLYFCJJSU-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-5-(3,4-difluorophenyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound C1=C(F)C(F)=CC=C1C1C2(CCN(CC2)C(=O)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)OC(=O)NC1 HGXVVFLYFCJJSU-UHFFFAOYSA-N 0.000 claims 1
- SEAFPVXMSCTQLM-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-5-(3-chlorophenyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CCC3(CC2)C(CNC(=O)O3)C=2C=C(Cl)C=CC=2)=C1 SEAFPVXMSCTQLM-UHFFFAOYSA-N 0.000 claims 1
- VEZFZDPMCIZCLQ-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-5-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CCC3(CC2)C(CNC(=O)O3)C=2C=CC=CC=2)=C1 VEZFZDPMCIZCLQ-UHFFFAOYSA-N 0.000 claims 1
- FDQWYVXLBAATDZ-UHFFFAOYSA-N 9-[3,5-bis(trifluoromethyl)benzoyl]-5-phenyl-3-(3-pyrrolidin-1-ylpropyl)-1-oxa-3,9-diazaspiro[5.5]undecan-2-one Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C(=O)N2CCC3(CC2)C(CN(CCCN2CCCC2)C(=O)O3)C=2C=CC=CC=2)=C1 FDQWYVXLBAATDZ-UHFFFAOYSA-N 0.000 claims 1
- DWEXTZOKBAVHDQ-UHFFFAOYSA-N FC(C=1C=C(C(=O)N2CCC3(C(C(N(C(O3)=O)C=3C=NC=CC3)C)C3=CC=CC=C3)CC2)C=C(C1)C(F)(F)F)(F)F Chemical compound FC(C=1C=C(C(=O)N2CCC3(C(C(N(C(O3)=O)C=3C=NC=CC3)C)C3=CC=CC=C3)CC2)C=C(C1)C(F)(F)F)(F)F DWEXTZOKBAVHDQ-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01111644 | 2001-05-14 | ||
| PCT/EP2002/004935 WO2002092604A1 (en) | 2001-05-14 | 2002-05-06 | 1-oxa-3,9-diaza-spiro'5,5!undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004534758A JP2004534758A (ja) | 2004-11-18 |
| JP2004534758A5 true JP2004534758A5 (https=) | 2005-08-25 |
| JP4056887B2 JP4056887B2 (ja) | 2008-03-05 |
Family
ID=8177412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002589488A Expired - Fee Related JP4056887B2 (ja) | 2001-05-14 | 2002-05-06 | １−オキサ−３，９−ジアザ−スピロ［５．５］ウンデカン−２−オン誘導体およびそのニューロキニン受容体拮抗剤としての使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6599900B2 (https=) |
| EP (1) | EP1390372B1 (https=) |
| JP (1) | JP4056887B2 (https=) |
| KR (1) | KR100618063B1 (https=) |
| CN (1) | CN1264847C (https=) |
| AR (1) | AR033631A1 (https=) |
| AT (1) | ATE401333T1 (https=) |
| AU (1) | AU2002342238B2 (https=) |
| BR (1) | BR0209604A (https=) |
| CA (1) | CA2447329C (https=) |
| DE (1) | DE60227657D1 (https=) |
| DK (1) | DK1390372T3 (https=) |
| ES (1) | ES2310206T3 (https=) |
| MX (1) | MXPA03010321A (https=) |
| PT (1) | PT1390372E (https=) |
| WO (1) | WO2002092604A1 (https=) |
| ZA (1) | ZA200308535B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2006132465A (ru) * | 2004-02-10 | 2008-03-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Модуляторы хемокинового рецептора ccr5 |
| KR20070094666A (ko) | 2005-02-25 | 2007-09-20 | 에프. 호프만-라 로슈 아게 | 약제 물질 분산성이 향상된 정제 |
| DE602006014531D1 (de) * | 2005-03-03 | 2010-07-08 | Janssen Pharmaceutica Nv | Substituierte oxadiazaspiro-ä5.5ü-undecanonderivate und ihre verwendung als neurokininantagonisten |
| NZ556628A (en) | 2005-03-08 | 2009-09-25 | Janssen Pharmaceutica Nv | Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists |
| US7470684B2 (en) * | 2007-01-03 | 2008-12-30 | Hoffmann-La Roche Inc. | Spiropiperidine derivatives as NK3 antagonists |
| EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
| WO2008119663A1 (en) | 2007-03-29 | 2008-10-09 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
| UA121775C2 (uk) | 2015-07-31 | 2020-07-27 | Пфайзер Інк. | 1,1,1-трифтор-3-гідроксипропан-2-ілкарбаматні похідні та 1,1,1-трифтор-4-гідроксибутан-2-ілкарбаматні похідні як інгібітори magl |
| EP3571191A1 (en) | 2017-01-20 | 2019-11-27 | Pfizer Inc | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors |
| EP3571202B1 (en) | 2017-01-23 | 2021-06-30 | Pfizer Inc. | Heterocyclic spiro compounds as magl inhibitors |
| WO2020048826A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds |
| WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2131021B (en) * | 1982-11-24 | 1985-12-18 | Erba Farmitalia | Antipsychotic benzoxazines |
| IL111960A (en) * | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
| WO1997011940A1 (en) * | 1995-09-29 | 1997-04-03 | Eli Lilly And Company | Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
-
2002
- 2002-05-06 CN CNB028094735A patent/CN1264847C/zh not_active Expired - Fee Related
- 2002-05-06 EP EP02742943A patent/EP1390372B1/en not_active Expired - Lifetime
- 2002-05-06 AT AT02742943T patent/ATE401333T1/de not_active IP Right Cessation
- 2002-05-06 KR KR1020037014713A patent/KR100618063B1/ko not_active Expired - Fee Related
- 2002-05-06 PT PT02742943T patent/PT1390372E/pt unknown
- 2002-05-06 DK DK02742943T patent/DK1390372T3/da active
- 2002-05-06 DE DE60227657T patent/DE60227657D1/de not_active Expired - Lifetime
- 2002-05-06 MX MXPA03010321A patent/MXPA03010321A/es active IP Right Grant
- 2002-05-06 ES ES02742943T patent/ES2310206T3/es not_active Expired - Lifetime
- 2002-05-06 JP JP2002589488A patent/JP4056887B2/ja not_active Expired - Fee Related
- 2002-05-06 AU AU2002342238A patent/AU2002342238B2/en not_active Ceased
- 2002-05-06 WO PCT/EP2002/004935 patent/WO2002092604A1/en not_active Ceased
- 2002-05-06 CA CA002447329A patent/CA2447329C/en not_active Expired - Fee Related
- 2002-05-06 BR BR0209604-8A patent/BR0209604A/pt not_active IP Right Cessation
- 2002-05-10 AR ARP020101705A patent/AR033631A1/es unknown
- 2002-05-10 US US10/143,431 patent/US6599900B2/en not_active Expired - Fee Related
-
2003
- 2003-10-31 ZA ZA200308535A patent/ZA200308535B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004534758A5 (https=) | ||
| CA2411716A1 (en) | 1,3,8-triaza-spiro [4.5] decan derivatives | |
| HUP0301671A2 (hu) | 4-Fenil-piridin-származékok, mint neurokinin-1-receptor antagonisták, eljárás az előállításukra és alkalmazásuk | |
| JP2014528433A5 (https=) | ||
| JP2021527043A5 (https=) | ||
| JP2005511699A5 (https=) | ||
| RU2005104434A (ru) | Производные 1-гетероциклилалкил-3-сульфонилиндола или - индазола как лиганды 5-гидрокситриптамина-6 | |
| JP2006523194A5 (https=) | ||
| JP2021530442A5 (https=) | ||
| JP2004525174A5 (https=) | ||
| NO20003723L (no) | Triazol- og imidazolderivater | |
| JP2005511532A5 (https=) | ||
| RU2004139068A (ru) | 1-(аминоалкил)-3-сульфонилазаиндолы в качестве лиганов 5-гидрокситриптамина-6 | |
| JP2005505618A5 (https=) | ||
| JP2005519932A5 (https=) | ||
| JP2006501201A5 (https=) | ||
| JP2006523193A5 (https=) | ||
| JP2005508967A5 (https=) | ||
| JP2008505157A5 (https=) | ||
| JP2004532240A5 (https=) | ||
| MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
| JP2007507494A5 (https=) | ||
| RU2007130144A (ru) | Гетероциклические соединения в качестве антагонистов cccr2b | |
| JP2004517130A5 (https=) | ||
| RU2009103300A (ru) | Производные 2-бензоилимидазопиридинов, их получение и их применение в терапии |